VIOLIN Logo
Cov19VaxKB Banner
Search: for Help
Home
Introduction
Statistics
Authorized Vaccines
Phase III Vaccines
Phase II Vaccines
Phase I Vaccines
Preclinical Vaccines
Vaccine Safety
Vaccine Design
News
Data Submission
Data Exchange
Data Download
Links
Documentation
Updates
Acknowledgements
FAQs
Disclaimer
Contact Us
UMMS Logo

Phase II COVID-19 Vaccines

This site presents COVID-19 vaccines that are currently in Phase II clinical trials as of February 17, 2021.

Current Phase II COVID-19 vaccines include:

  1. AdCLD-CoV19
    • Clinical trial ID:
      • Phase I/II: NCT04666012
        • Age subgroups: 19-64 years
        • Location: South Korea
    • Type: Recombinant vector vaccine
    • Manufacturer: Cellid Co., Ltd.
    • VIOLIN: 5800
    • VO: VO_0004996
  2. AKS-452
    • Clinical trial ID:
      • Phase I/II: NCT04681092
        • Age subgroups: 18-55 years
        • Location: Netherlands
    • Type: Subunit vaccine
    • Manufacturer: University Medical Center Groningen, Akston Biosciences Inc.
    • VIOLIN: 5834
    • VO: VO_0004999
  3. ARCT-021
    • Other names: LUNAR-COV19
    • Clinical trial ID:
      • Phase II: NCT04728347
        • Age subgroups: 21-80 years
        • Location: Singapore
      • Phase I/II: NCT04480957
        • Age subgroups:
          • Phase I: 21-55 years
          • Phase II: 21-55 years, 56-80 years
        • Location: Singapore
    • Type: mRNA vaccine
    • Manufacturer: Arcturus Therapeutics, Duke-NUS Medical School
    • VIOLIN: 5781
    • VO: VO_0005164
  4. AV-COVID-19
    • Clinical trial ID:
      • Phase I/II: NCT04386252
        • Age subgroups: 18 years and older
        • Location: USA
    • Type: Recombinant vector vaccine
    • Manufacturer: Aivita Biomedical, Inc.
    • VIOLIN: 5801
    • VO: VO_0005079
  5. BECOV2A
    • Clinical trial ID:
      • Phase I/II: CTRI/2020/11/029032
        • Age subgroups:
          • Phase I: 18-55 years
          • Phase II: 18-65 years
        • Location: India
    • Type: Subunit vaccine
    • Manufacturer: Biological E
    • VIOLIN: 5802
    • VO: VO_0005081
  6. CIGB-66
    • Clinical trial ID:
      • Phase I/II: RPCEC00000346
        • Age subgroups:
          • Phase I: 19-54 years
            Phase II: 19-80 years
        • Location: Cuba
    • Type: Subunit vaccine
    • Manufacturer: Center for Genetic Engineering and Biotechnology (CIGB)
    • VIOLIN: 5803
    • VO: VO_0005082
  7. CIGB-669
    • Clinical trial ID:
      • Phase I/II: RPCEC00000345
        • Age subgroups:
          • Phase I: 19-54 years
            Phase II: 19-80 years
        • Location: Cuba
    • Type: Subunit vaccine
    • Manufacturer: Center for Genetic Engineering and Biotechnology (CIGB)
    • VIOLIN: 5804
    • VO: VO_0005083
  8. COVAC
    • Clinical trial ID:
      • Phase I/II: NCT04702178
        • Age subgroups: 18-54 years, 55-69 years, 70 years and above
        • Location: Canada
    • Type: Subunit vaccine
    • Manufacturer: Vaccine and Infectious Disease Organization (VIDO), SEPPIC, Vaccine Formulation Institute (VFI)
  9. COVID-19 inactivated virus vaccine by Shenzhen Kangtai Biological Products
    • Clinical trial ID:
    • Type: Inactivated or "killed" vaccine
    • Manufacturer: Shenzhen Kangtai Biological Products Co., Ltd.
    • VIOLIN: 5805
    • VO: VO_0005084
  10. COVID-19 protein subunit vaccine by Sanofi and GSK
    • Clinical trial ID:
      • Phase I/II: NCT04537208
        • Age subgroups: 18-49 years, 50 years and above
        • Location: USA
    • Type: Subunit vaccine
    • Manufacturer: Sanofi Pasteur, GSK
    • VIOLIN: 5833
    • VO: VO_0005085
  11. DelNS1-2019-nCoV-RBD-OPT1
    • Clinical trial ID:
    • Type: Recombinant vector vaccine
    • Manufacturer: Beijing Wantai Biological Pharmacy, Xiamen University
    • VIOLIN: 5806
    • VO: VO_0005087
  12. GBP510
    • Clinical trial ID:
      • Phase I/II: NCT04750343
        • Age subgroups:
          • Phase I: 19-55 years
          • Phase II: 19-85 years
        • Location: South Korea
    • Type: Subunit vaccine
    • Manufacturer: SK Bioscience Co., Ltd.
    • VIOLIN: 5831
  13. GLS-5310
    • Clinical trial ID:
      • Phase I/II: NCT04673149
        • Age subgroups:
          • Phase I: 19-50 years
          • Phase II: 19-65 years
        • Location: South Korea
    • Type: DNA vaccine
    • Manufacturer: GeneOne Life Science, Inc.
    • VIOLIN: 5807
    • VO: VO_0005089
  14. GX-19
    • Clinical trial ID:
      • Phase I/II: NCT04715997
        • Age subgroups: 18-55 years
        • Location: South Korea
      • Phase I/II: NCT04445389
        • Age subgroups: 18-50 years
        • Location: South Korea
    • Type: DNA vaccine
    • Manufacturer: Genexine
    • VIOLIN: 5788
    • VO: VO_0005170
  15. IIBR-100
    • Other names: BriLife
    • Clinical trial ID:
      • Phase I/II: NCT04608305
        • Age subgroups:
          • Phase I: 18-55 years
          • Phase II: 18-55 years, 56-85 years
        • Location: Israel
    • Type: Recombinant vector vaccine
    • Manufacturer: Israel Institute for Biological Research, Weizmann Institute of Science
    • VIOLIN: 5799
    • VO: VO_0005090
  16. KBP-COVID-19
    • Clinical trial ID:
      • Phase I/II: NCT04473690
        • Age subgroups: 18-49 years, 50-70 years
    • Type: Subunit vaccine
    • Manufacturer: Kentucky BioProcessing
    • VIOLIN: 5792
    • VO: VO_0005171
  17. LV-SMENP-DC
    • Clinical trial ID:
      • Phase I/II: NCT04276896
        • Age subgroups: 6 months to 80 years
        • Location: China
    • Type: Recombinant vector vaccine
    • Manufacturer: Shenzhen Geno-Immune Medical Institute
    • VIOLIN: 5808
    • VO: VO_0005091
  18. MVC-COV1901
    • Clinical trial ID:
      • Phase II: NCT04695652
        • Age subgroups: 20-64 years, 65 years and above
        • Location: Taiwan, Vietnam
    • Type: Subunit vaccine
    • Manufacturer: Medigen; Dynavax
    • VIOLIN: 5828
    • VO: VO_0005192
  19. Nanocovax
    • Clinical trial ID:
      • Phase I/II: NCT04683484
        • Age subgroups:
          • Phase I: 18-50 years
          • Phase II: 12-75 years
        • Location: Vietnam
    • Type: Subunit vaccine
    • Manufacturer: Nanogen Pharmaceutical Biotechnology
    • VIOLIN: 5809
    • VO: VO_0005092
  20. QazCovid-in
    • Clinical trial ID:
      • Phase II: NCT04530357
        • Age subgroups:
          • Phase I: 18-50 years
          • Phase II: 18 years and above
        • Location: Kazakhstan
    • Type: Inactivated or "killed" vaccine
    • Manufacturer: Research Institute for Biological Safety Problems, National Scientific Center for Phthisiopulmonology of the Republic of Kazakhstan
    • VIOLIN: 5810
    • VO: VO_0005093
  21. RBD-HBsAg VLP
    • Clinical trial ID:
      • Phase I/II: ACTRN12620000817943
        • Age subgroups:
          • Phase I: 18-45 years
          • Phase II: 18-79 years
        • Location: Australia
    • Type: Virus Like Particle
    • Manufacturer: Serum Institute of India, Accelegen Pty
    • VIOLIN: 5811
    • VO: VO_0005094
  22. Recombinant SARS-CoV-2 vaccine (Sf9 cell)
    • Clinical trial ID:
      • Phase II: NCT04640402
        • Age subgroups: 18-59 years, 60 years and above
        • Location: China
      • Phase II: NCT04718467
        • Age subgroups: 18-59 years, 60 years and above
        • Location: China
    • Type: Subunit vaccine
    • Manufacturer: West China Hospital, Sichuan University
    • VIOILN: 5812
    • VO: VO_0005095
  23. S-268019
    • Clinical trial ID:
      • Phase I/II: jRCT2051200092
        • Age subgroups: 20-64 years
        • Location: Japan
    • Type: Subunit vaccine
    • Manufacturer: Shionogi
    • VIOLIN: 5813
    • VO: VO_0005096
  24. Soberana
    • Clinical trial ID:
      • Phase I/II: IFV/COR/04
        • Age subgroups: 19-59 years, 60-80 years
        • Location: Cuba
      • Phase II: IFV/COR/08
        • Age subgroups: 19-80 years
        • Location: Cuba
    • Type: Subunit vaccine
    • Manufacturer: Instituto Finlay de Vacunas, Cuba
    • VIOLIN: 5814
    • VO: VO_0005097
  25. VLA2001
    • Clinical trial ID:
      • Phase I/II: NCT04671017
        • Age subgroups: 18-55 years
        • Location: UK
    • Type: Inactivated or "killed" vaccine
    • Manufacturer: Valneva, National Institute for Health Research (UK)
    • VIOLIN: 5816
    • VO: VO_0005099
  26. ZyCoV-D
    • Clinical trial ID:
      • Phase I/II: CTRI/2020/07/026352
        • Age subgroups:
          • Phase I: 18-45 years
          • Phase II: 18-79 years
        • Location: Australia
    • Type: DNA vaccine
    • Manufacturer: Zydus Cadila
    • VIOLIN: 5778
    • VO: VO_0005162

Provenance: All data in Cov19VaxKB originates from manual curation of reliable resources

Note: The page was updated on February 17, 2021. We plan to update this page on a weekly or even a daily basis. Please provide us with any new information that you believe would be useful if included on the website.